Connection

Chong Yu to Comorbidity

Back to Details
This is a "connection" page, showing publications Chong Yu has written about Comorbidity.
Chong Yu
Connection Strength
0.128
Comorbidity
  1. Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease. Respir Res. 2019 Apr 05; 20(1):69.
    View in: PubMed
    Score: 0.034
  2. Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan. Cancer Med. 2017 Jul; 6(7):1563-1572.
    View in: PubMed
    Score: 0.030
  3. Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality. PLoS One. 2017; 12(4):e0175794.
    View in: PubMed
    Score: 0.030
  4. Characteristics of patients with kidney injury associated with COVID-19. Int Immunopharmacol. 2021 Jul; 96:107794.
    View in: PubMed
    Score: 0.010
  5. Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units. J Microbiol Immunol Infect. 2019 Apr; 52(2):320-328.
    View in: PubMed
    Score: 0.008
  6. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients. J Formos Med Assoc. 2019 Jan; 118(1 Pt 3):429-435.
    View in: PubMed
    Score: 0.008
  7. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12:2987-2996.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.